RxDoctor Payments Data

Lauren Morton

Psychiatric/Mental Health · Leland, NCNPI 1871220442

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,464in general payments, 2019–2025

Across 302 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$677
  • Otsuka America Pharmaceutical, Inc.$538
  • Neurocrine Biosciences, Inc.$529
  • Johnson & Johnson$523
  • Axsome Therapeutics, Inc.$461
  • Vanda Pharmaceuticals Inc.$402
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$6,464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,464 in reported general payments places this provider in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelsomraSuvorexant30$12,842
Desvenlafaxine Succinate ErDesvenlafaxine Succinate31$2,197
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine36$1,501
Trazodone Hcl63$1,071
Bupropion XlBupropion Hcl59$891
Gabapentin60$809
Lamotrigine63$547
Divalproex Sodium ErDivalproex Sodium17$525
Buspirone Hcl23$422
Venlafaxine Hcl ErVenlafaxine Hcl14$371
Aripiprazole27$282
Lorazepam15$243
Escitalopram Oxalate23$220
Sertraline Hcl28$211
Quetiapine Fumarate35$210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckBelsomra$114$12,84230 claims
Almatica Pharma LLCSertraline Hcl$317$21128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Leland

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →